An Open-Label Extension Study for Patients With Duchenne Muscular Dystrophy Who Participated in Studies of SRP-5051



Status:Recruiting
Conditions:Neurology
Therapuetic Areas:Neurology
Healthy:No
Age Range:12 - Any
Updated:1/25/2019
Start Date:December 19, 2018
End Date:November 1, 2020
Contact:Medical information
Email:clinicaltrials@sarepta.com
Phone:+1 888 727 3782

Use our guide to learn which trials are right for you!

The purpose of this extension study is to evaluate the safety, tolerability, and
pharmacokinetics of repeat administrations of SRP-5051 in patients with Duchenne muscular
dystrophy (DMD) who participated in studies of SRP-5051.


Inclusion Criteria:

• Has completed Study 5051-101 (NCT03375255) and continues to meet the Safety Eligibility
Criteria of Study 5051-101 (NCT03375255).

Exclusion Criteria:

- Initiation or change of dosing (except for modifications to accommodate changes in
weight) since entering Study 5051-101 (NCT03375255) and while participating in this
study for any of the following: angiotensin converting enzyme (ACE) inhibitors,
angiotensin receptor blocking agents (ARBs), beta-blockers, potassium and steroids*.

- Requires antiarrhythmic and/or diuretic therapy for heart failure.

- Use of any herbal medication/supplement containing aristolochic acid.

- Treatment with any experimental therapy since entering original study or any
experimental gene therapy for the treatment of DMD at any time.

- Participation in an interventional clinical trial since completing original study.

Other inclusion/exclusion criteria apply.

* The dose of steroids must remain constant except for modifications to accommodate changes
in weight.
We found this trial at
4
sites
4401 Penn Avenue
Pittsburgh, Pennsylvania 15224
412-692-5325
Principal Investigator: Hoda Abdel-Hamid, MD
Phone: 412-692-5176
Children's Hospital of Pittsburgh of UPMC UPMC is one of the leading nonprofit health systems...
?
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
Atlanta, Georgia 30318
Principal Investigator: Han C Phan, MD
Phone: 678-883-6897
?
mi
from
Atlanta, GA
Click here to add this to my saved trials
Gulf Breeze, Florida 32561
Principal Investigator: Weldon Mauney, MD
Phone: 850-934-1299
?
mi
from
Gulf Breeze, FL
Click here to add this to my saved trials
3901 Rainbow Blvd
Kansas City, Kansas 66160
(913) 588-5000
Principal Investigator: Jeffrey Statland, MD
Phone: 913-945-9928
University of Kansas Medical Center The University of Kansas Medical Center serves Kansas through excellence...
?
mi
from
Kansas City, KS
Click here to add this to my saved trials